FDA Announces Recall of Abbott Glucose Test Strips

December 22, 2010

FDA Announces Recall of Abbott Glucose Test Strips

The U.S. Food and Drug Administration today announced that the agency is working with Abbott Diabetes Care to recall 359 different lots of glucose test strips that were sold between January and May 2010 and marketed under the following brand names:

• Precision Xceed Pro
• Precision Xtra
• Medisense Optium
• Optium, OptiumEZ
• and ReliOn Ultima

These test strips may give falsely low blood glucose results, which can lead patients to try to raise their blood glucose when it is unnecessary, or to fail to treat elevated blood glucose due to a falsely low reading.

The FDA has provided specific recommendations for patients and healthcare professionals with regard to the recalled products. Additional information about this recall can be found at FDA announces recall of Abbott glucose test strips and Questions and Answers About the Abbott Glucose Test Strip Recall.

For more information, please contact Stephanie Kutler, Director of Government Affairs, at skutler@endo-society.org.